Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
12-Week-Combined Physical Training In Heart Failure Patients
NCT02571270
Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)
NCT02636439
Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction
NCT02762825
Hospital Versus Home Based Exercise in Patients With Chronic Stable Heart Failure
NCT01480921
Resistance Training in HFpEF
NCT02435667
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Training
Exercise Training
Study subjects will receive medically supervised aerobic and resistance exercise training for 1 hour per session, 3 times per week for 6 weeks at the Cardiac Rehab center and then transition to home or YMCA partnership based exercise with staff follow-up contact for an additional 3 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Training
Study subjects will receive medically supervised aerobic and resistance exercise training for 1 hour per session, 3 times per week for 6 weeks at the Cardiac Rehab center and then transition to home or YMCA partnership based exercise with staff follow-up contact for an additional 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of HFPEF stable NYHA Stage II- III with an EF of ≥ 45%
* Stabilized on cardiac medications and post hospitalization \> 4 weeks
* Ability to participate in exercise testing and training.
* Referral from Cardiologist or primary care physician.
Exclusion Criteria
* Uncontrolled diabetes
* Moderate to severe aortic stenosis
* Uncontrolled hypertension Systolic BP\>150 mm Hg or Diastolic BP \>100 mm Hg
* Valvular heart disease
* Untreated coronary artery stenosis \>50%
* Arrhythmias
* Pulmonary disease/COPD
* Dementia or cognitive impairment
* VAD or Transplant planned in next 6 months.
* Current or recent participation in a Cardiac Rehab program within the last six months.
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henry Ford Hospital
OTHER
MultiCare Health System Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MultiCare Health System
Tacoma, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bean G, Mou J, Pflugeisen B, Olsen L, Hoag S, Silva A, Ball AL, Lee T. Exercise Training in Patients With Heart Failure With Preserved Ejection Fraction: A Community Hospital Pilot Study. J Cardiovasc Nurs. 2021 Mar-Apr 01;36(2):124-130. doi: 10.1097/JCN.0000000000000737.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15.20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.